Felix Burda Foundation

Last updated
Felix Burda Foundation
Felix Burda Stiftung
Formation2001
FounderHubert Burda, Christa Maar
TypeRegistered charity (Germany)
HeadquartersOffenburg
Key people
Robert Schweizer (chair), Berndt Birkner and Meinhard Classen
Endowment 300,000 euros
Website www.felix-burda-stiftung.de

The Felix Burda Foundation is a German charitable foundation based in Offenburg. It was founded in 2001 by Christa Maar and Hubert Burda to improve the early detection of colorectal cancer. [1] Among its most well-known initiatives is the "Darmkrebsmonat" or "Colon Cancer Month" in March. [2]

Contents

History

In 2001 Felix Burda died of colon cancer at the age of 33. [3] Believing he could have been cured had the disease been recognized earlier, [4] Burda's parents, Christa Maar and Hubert Burda, initiated the Felix Burda Foundation to raise public awareness of the risk of colorectal cancer. [5] Their goal was to halve the colorectal cancer rate within five years. [6]

Leading doctors supported the foundation in its efforts, [7] and in 2001 Wim Wenders created a televised public service announcement for the foundation. [8]

Colon Cancer month

In 2002, thanks to the Foundation's efforts, March was declared "Colon Cancer Month" to increase media coverage of the issue. [9] Campaigns on the topic of colon cancer prevention and detection are displayed annually in March. [10]

Following the Foundation's campaigning, from 2002 German health insurance was legally required to cover a colonoscopy for all insured people over 55 and a followup procedure ten years later. [11]

Within a year of the first Colon Cancer Month, the number of colonoscopies increased by 34%, which the Foundation saw as a sign of the success of its work. [12] In order to increase this number, health insurance funds were required to offer bonuses to make screenings more attractive to those they insured. [13]

The Felix Burda Award

The Felix Burda Award was created in 2003 [14] to honor individuals who have made outstanding contributions to the prevention and early detection of colorectal cancer, whether through innovative campaigns, projects or scientific work. [15] Among the first winners were Kai Diekmann, Günther Jauch and Susan Stahnke. [16]

Other campaigns

The Foundation enlisted Franz Beckenbauer, Maria Furtwängler, Verona Pooth and Harald Schmidt as ambassadors. [17] [18] [19] [20] The Foundation has also campaigned to emphasise early detection for men, who are statistically more at risk of developing colorectal cancer, [21] and for pharmacists to inform their customers about colorectal cancer risk and screenings. [22]

In 2008, the Foundation presented a walk-in model of a colon, to explain the anatomy and function of the organ. [23] About 20 meters long and 2.80 meters high, it is the largest replica of the colon in Europe. [24] The model can be rented and has toured several cities, appearing in public places such as Frankfurt Central Station, [25] along with medical specialists answering questions from visitors. [26] In addition, the Foundation intensified its cooperation with companies to fight colon cancer. [27] [28]

The Foundation was awarded the Special Prize of the German Prize for Business Communication 2009. [29]

The Foundation has worked to incorporate other risk factors, such as a family history of diabetes, into colorectal cancer screening. [30] In 2011, in cooperation with the Assmann Foundation for Prevention, the Foundation launched a mobile app that provides information on measures to prevent various illnesses. [31] [32] The Foundation participated in Germany's National Cancer Plan and helped draft guidelines incorporated into the 2013 Cancer Screening and Registration Act (KFRG). [1] [33] For instance, the foundation called for the introduction of immunological stool tests, which were included in the catalog of benefits for health insurance in 2017. [11] These tests use the smallest traces of blood in the stool, a recognized sign of colorectal cancer, to detect cancer more precisely than traditional stool tests developed in the 1970s. [34] [35]

Recently, the Foundation has worked to address the specific needs of people with a family history of colorectal cancer and to improve the organisation of colon cancer screenings. [33]

Organization

The Felix Burda Foundation is an independent charitable foundation managed in trust by the Hubert Burda Foundation. The registered office is in Offenburg with an office in Munich.The purpose of the foundation is teaching and research in the field of cancer prevention, detection, and control, in particular of colon cancer. It accomplishes its goals through various forms of public relations, such as the organization of conferences or the publication of teaching and training materials.

The Foundation is involved in international organizations in order to promote the exchange of experts in its field. In the early years, for example, colorectal cancer screening in the United States, which had a higher participation and a lower mortality rate than Germany, was an important model for the foundation. [35]

The Foundation has an endowment of 300,000 euros. It is governed by an honorary board of trustees of three to five persons. Christa Maar and Hubert Burda are lifetime members. Other board members are appointed for a term of three, four or five years. In addition to Maar and Burda, the body currently includes internists and gastroenterologists Berndt Birkner and Meinhard Classen. The operational management of the foundation is the responsibility of a board chaired by Robert Schweizer. Other members include Heinz Spengler and Christa Maar, the foundation's managing director. [36]

Related Research Articles

<span class="mw-page-title-main">Colorectal cancer</span> Cancer of the colon or rectum

Colorectal cancer (CRC), also known as bowel cancer, colon cancer, or rectal cancer, is the development of cancer from the colon or rectum. Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, and fatigue. Most colorectal cancers are due to old age and lifestyle factors, with only a small number of cases due to underlying genetic disorders. Risk factors include diet, obesity, smoking, and lack of physical activity. Dietary factors that increase the risk include red meat, processed meat, and alcohol. Another risk factor is inflammatory bowel disease, which includes Crohn's disease and ulcerative colitis. Some of the inherited genetic disorders that can cause colorectal cancer include familial adenomatous polyposis and hereditary non-polyposis colon cancer; however, these represent less than 5% of cases. It typically starts as a benign tumor, often in the form of a polyp, which over time becomes cancerous.

<span class="mw-page-title-main">Colonoscopy</span> Examination of the bowel

Colonoscopy or coloscopy is a medical procedure involving the endoscopic examination of the large bowel (colon) and the distal portion of the small bowel. This examination is performed using either a CCD camera or a fiber optic camera, which is mounted on a flexible tube and passed through the anus.

<span class="mw-page-title-main">Fecal occult blood</span> Medical condition

Fecal occult blood (FOB) refers to blood in the feces that is not visibly apparent. A fecal occult blood test (FOBT) checks for hidden (occult) blood in the stool (feces).

<span class="mw-page-title-main">Hereditary nonpolyposis colorectal cancer</span> Autosomal dominant genetic condition associated with a high risk of cancer in the colon

Hereditary nonpolyposis colorectal cancer (HNPCC) is a hereditary predisposition to colon cancer.

<span class="mw-page-title-main">Virtual colonoscopy</span> Medical imaging of the colon

Virtual colonoscopy is the use of CT scanning or magnetic resonance imaging (MRI) to produce two- and three-dimensional images of the colon, from the lowest part, the rectum, to the lower end of the small intestine, and to display the images on an electronic display device. The procedure is used to screen for colon cancer and polyps, and may detect diverticulosis. A virtual colonoscopy can provide 3D reconstructed endoluminal views of the bowel. VC provides a secondary benefit of revealing diseases or abnormalities outside the colon.

<span class="mw-page-title-main">Maria Furtwängler</span> German physician and actress

Maria Furtwängler-Burda is a German physician and television actress.

<i>Bunte</i> German magazine

Bunte is a German-language weekly celebrity gossip magazine published by Hubert Burda Media. The first edition was published in 1948 under the name Das Ufer. Under the leadership of Hubert Burda, Bunte developed into a modern popular magazine. In 2014, Bunte was the 11th most popular media brand in Germany, with 10.57 million monthly users. After Patricia Riekel stepped down, Robert Pölzer took over as Editor-in-Chief in July 2016.

<span class="mw-page-title-main">Hubert Burda Media</span> German media group

Hubert Burda Media Holding is a German media group with headquarters in Offenburg. It originated as a small printing business, founded by Franz Burda Snr in Philippsburg, in 1903.

<span class="mw-page-title-main">Hubert Burda</span> German publisher

Hubert Burda is a German billionaire publisher. He is the owner, publisher and general partner of Hubert Burda Media, a global media company of more than 600 media products, including websites, print magazines and other brands. It operates in 20 countries, predominantly in Germany and the UK. Its brands include Focus, Bunte and Radio Times.

<span class="mw-page-title-main">Stool guaiac test</span> Test for the presence for occult blood

The stool guaiac test or guaiac fecal occult blood test (gFOBT) is one of several methods that detects the presence of fecal occult blood. The test involves placing a fecal sample on guaiac paper and applying hydrogen peroxide which, in the presence of blood, yields a blue reaction product within seconds.

<i>Focus</i> (German magazine) German weekly news magazine

Focus is a German-language news magazine published by Hubert Burda Media. Established in 1993 as an alternative to the Der Spiegel weekly news magazine, since 2015 the editorial staff has been headquartered in Germany's capital of Berlin. Alongside Spiegel and Stern, Focus is one of the three most widely circulated German weeklies. The concept originated from Hubert Burda and Helmut Markwort, who went from being Editor-in-chief to become publisher in 2009 and since 2017 has been listed in the publication's masthead as founding editor-in-chief. As of March 2016 the editor-in-chief of Focus was Robert Schneider.

<span class="mw-page-title-main">Elfie Wörner</span> German journalist and humanitarian (1941–2006)

Elfie Wörner was a German journalist, humanitarian and the second wife of Manfred Wörner, who served as the Secretary General of NATO. Elfie Wörner took part in numerous charitable and other non-governmental activities, and was the patron of the German Army Social Work Society, the Special Children in German Military Families, and the Manfred Wörner Foundation, and was a member of the advisory board of Hilfe für Bosnien-Herzegowina.

Von hier aus – Zwei Monate neue deutsche Kunst in Düsseldorf is the title of an art exhibition from 29 September 1984 to 2 December 1984. It was organised by the city of Düsseldorf and the Gesellschaft für aktuelle Kunst Düsseldorf e.V. and was curated by Kasper König.

<span class="mw-page-title-main">Cancer screening</span> Method to detect cancer

The objective of cancer screening is to detect cancer before symptoms appear, involving various methods such as blood tests, urine tests, DNA tests, and medical imaging. The purpose of screening is early cancer detection, to make the cancer easier to treat and extending life expectancy. As of 2023, cancer is the second leading cause of death in the United States.

<span class="mw-page-title-main">Liz Mohn</span> German businesswoman and philanthropist

Elisabeth Mohn is a German billionaire businesswoman and philanthropist. She was married to Reinhard Mohn until his death in 2009.

<span class="mw-page-title-main">Exact Sciences (company)</span> American company in Madison, United States

Exact Sciences Corp. is a molecular diagnostics company based in Madison, Wisconsin specializing in the detection of early stage cancers. The company's initial focus was on the early detection and prevention of colorectal cancer; in 2014 it launched Cologuard, the first stool DNA test for colorectal cancer. Since then Exact Sciences has grown its product portfolio to encompass other screening and precision oncological tests for other types of cancer.

Cornelia "Neli" Ulrich is executive director of the Comprehensive Cancer Center at Huntsman Cancer Institute (HCI), Jon M. and Karen Huntsman Presidential Professor in Cancer Research, and former Division Chief of Cancer Population Sciences in the Department of Population Health Sciences at the University of Utah. Ulrich oversees HCI's academic consortium of nearly 200 cancer research teams. She leads efforts to advance the impact of HCI's research in laboratory, clinical and population science, with the goal of improving cancer prevention and treatment. Prior to joining HCI, she was the director and department head of preventive oncology at the National Center of Tumor Diseases (NCT) and German Cancer Research Center (DKFZ) in Heidelberg. During this time, she also held a Professorship at the DKFZ and University of Heidelberg. From 1993 until 2009, Ulrich was a Member of the Fred Hutchinson Cancer Research Center and Professor in Epidemiology at the University of Washington in Seattle.

<span class="mw-page-title-main">Brigitte Mohn</span> German businesswoman and philanthropist

Brigitte Mohn is a German businesswoman and a member of the Mohn family that has a significant influence on Bertelsmann group and the Bertelsmann Stiftung. Mohn is also chair of the German Stroke Foundation's executive board.

<span class="mw-page-title-main">Serrated polyposis syndrome</span> Medical condition

Serrated polyposis syndrome (SPS), previously known as hyperplastic polyposis syndrome, is a disorder characterized by the appearance of serrated polyps in the colon. While serrated polyposis syndrome does not cause symptoms, the condition is associated with a higher risk of colorectal cancer (CRC). The lifelong risk of CRC is between 25 and 40%. SPS is the most common polyposis syndrome affecting the colon, but is under recognized due to a lack of systemic long term monitoring. Diagnosis requires colonoscopy, and is defined by the presence of either of two criteria: ≥5 serrated lesions/polyps proximal to the rectum, or >20 serrated lesions/polyps of any size distributed throughout the colon with 5 proximal to the rectum.

<span class="mw-page-title-main">Melanie Brinkmann</span> German virologist

Melanie Brinkmann is a German virologist. Until 2019 she was probably best known in connection with her work on the Cytomegalovirus. During 2020 she emerged as a much consulted expert-pundit for media commentators keen to discuss the COVID-19 pandemic. Brinkmann took a robust public position in the campaign against pandemic misinformation: she described the so-called "virus of false information" as "more deadly than the [COVID-19] virus itself".

References

  1. 1 2 "15 Jahre Kampf gegen Darmkrebs". Ärzte Zeitung. 4 November 2016.
  2. ↑ Lörcks, Julia (30 March 2009). "Die Angst im Gespräch nehmen. Darmkrebsmonat März". Rheinische Post.
  3. ↑ "Felix Burda ist tot". Die Welt. 26 February 2001. Retrieved 20 May 2019.
  4. ↑ Bartholomäus, Ulrike (17 March 2008). "Felix könnte noch leben". Focus.
  5. ↑ Binder, Elisabeth (12 May 2015). "Mit den Waffen einer Lobbyistin". Der Tagesspiegel.
  6. ↑ "Die Darmkrebsrate soll in fünf Jahren halbiert werden". Ärzte Zeitung. 26 March 2001.
  7. ↑ "Joachim Mangler: Früherkennung rettet Leben". Sächsische Zeitung. 23 October 2001.
  8. ↑ "Klüger werden mit Wim Wenders". Der Spiegel. 22 December 2001. Retrieved 20 May 2019.
  9. ↑ Lossau, Norbert (17 December 2001). "März 2002 wird Darmkrebsmonat". Die Welt.
  10. ↑ "Die Werbekampagne".
  11. 1 2 Lossau, Norbert (20 March 2017). "Ausreden können tödlich sein". Die Welt.
  12. ↑ "Darmkrebs: Vorbildlich, diese Stars". Bunte. 30 April 2003.
  13. ↑ "Trend zum Früh-Test". Focus. 16 February 2004.
  14. ↑ "Engagierte Stars im Hotel Adlon". Focus Online. 7 April 2008. Retrieved 21 May 2019.
  15. ↑ "Felix Burda Award für Engagement gegen Darmkrebs". Ärzte Zeitung. 6 October 2003.
  16. ↑ Renz, Gabriele (7 April 2003). "Ja, wo sind sie denn? Dem Boulevard war zu wenig Prominenz bei der Gala "Stars mit Mut", doch für Stuttgart war es reichlich". Südkurier .
  17. ↑ "Der Kaiser zeigt, was in ihm steckt". Bunte. 25 March 2004.
  18. ↑ Schmidt, Walter (22 March 2004). "Ihr ganz großes Problem sind die Männer". Main-Port.
  19. ↑ Renz, Christian (8 March 2004). "Verona, die Spenden-Jägerin". Berliner Kurier.
  20. ↑ Lossau, Norbert (6 March 2006). "Harald Schmidt wirbt für Vorsorge". Die Welt. Retrieved 21 May 2019.
  21. ↑ Werner, Cornelia (27 February 2009). "Männer haben höheres Darmkrebs-Risiko". Hamburger Abendblatt. Retrieved 21 May 2019.
  22. ↑ "Information und Vorsorge können das Leben retten". Aachener Zeitung. 15 March 2008.
  23. ↑ "Im Darm-Modell geht es windig zu". Ärzte Zeitung. 30 October 2008. Retrieved 21 May 2019.
  24. ↑ "Aktiv gegen Krebs. Europas größter begehbarer Darm in Bad Honnef". Bonner General-Anzeiger. 28 January 2009.
  25. ↑ Smith, Pete (27 February 2009). "Großes Staunen im begehbaren Darm". Ärzte Zeitung. Retrieved 21 May 2019.
  26. ↑ "Was für ein Organ". Abendzeitung. 3 March 2009.
  27. ↑ "Darmkrebs ist auch Thema für Betriebe". Ärzte Zeitung. 10 March 2008. Retrieved 21 May 2019.
  28. ↑ "Kampf gegen Darmkrebs: Firmen helfen bei der Prävention". Ärzte Zeitung. 11 March 2015. Retrieved 21 May 2019.
  29. ↑ "Fressnapf bekommt Deutschen Preis für Wirtschaftskommunikation". Werben & Verkaufen. 22 May 2009. Retrieved 21 May 2019.
  30. ↑ "Fast alle Diabetes-Fälle sind vermeidbar". Die Welt. 22 June 2005.
  31. ↑ Niehaus, Jochen (10 January 2011). "Dosiert: App zum Arz". Focus. Retrieved 21 May 2019.
  32. ↑ "Präventions-App organisiert Vorsorge". Ärzte Zeitung. 23 March 2012. Retrieved 21 May 2019.
  33. 1 2 Schumacher, Beate (1 March 2017). "Darmkrebs: Hindernislauf zu einem organisierten Screening". Ärzte Zeitung. Retrieved 21 May 2019.
  34. ↑ Lossau, Norbert (20 March 2017). "Bessere Früherkennung". Die Welt Kompakt.
  35. 1 2 Klammer, Paul (11 March 2017). "Besser testen. Neue Methoden vereinfachen die Früherkennung von Darmkrebs". Focus.
  36. ↑ "Organisation Die Felix Burda Stiftung".
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.